{"Abstract": [0], "Diffuse": [1], "intrinsic": [2], "pontine": [3], "glioma": [4, 38], "(DIPG)": [5], "and": [6, 40, 81, 155, 174, 185, 199, 208], "other": [7], "H3K27M-mutated": [8, 37, 102, 224], "diffuse": [9], "midline": [10], "gliomas": [11], "(DMGs)": [12], "are": [13], "universally": [14], "lethal": [15], "paediatric": [16], "tumours": [17], "of": [18, 46, 152, 169, 190, 217], "the": [19, 30, 57, 93, 97, 150, 153, 183, 215], "central": [20], "nervous": [21], "system": [22], "1": [23, 116], ".": [24, 144], "We": [25], "have": [26, 41], "previously": [27], "shown": [28], "that": [29], "disialoganglioside": [31], "GD2": [32], "is": [33], "highly": [34], "expressed": [35], "on": [36], "cells": [39, 53, 112, 123, 193], "demonstrated": [42], "promising": [43], "preclinical": [44], "efficacy": [45], "GD2-directed": [47], "chimeric": [48], "antigen": [49], "receptor": [50], "(CAR)": [51], "T": [52, 69, 111, 122, 138, 196], "2": [54], ",": [55], "providing": [56], "rationale": [58], "for": [59, 135, 221], "a": [60], "first-in-human": [61], "phase": [62], "I": [63], "clinical": [64, 94, 131, 173], "trial": [65], "(NCT04196413).": [66], "Because": [67], "CAR": [68, 195], "cell-induced": [70], "brainstem": [71], "inflammation": [72], "can": [73], "result": [74], "in": [75, 182, 204], "obstructive": [76], "hydrocephalus,": [77], "increased": [78, 181], "intracranial": [79], "pressure": [80], "dangerous": [82], "tissue": [83], "shifts,": [84], "neurocritical": [85], "care": [86], "precautions": [87], "were": [88, 133, 180], "incorporated.": [89], "Here": [90], "we": [91], "present": [92], "experience": [95], "from": [96, 194], "first": [98], "four": [99, 170], "patients": [100, 171, 222], "with": [101, 109, 158, 223], "DIPG": [103, 225], "or": [104, 226], "spinal": [105, 227], "cord": [106, 228], "DMG": [107], "treated": [108], "GD2-CAR": [110, 121, 137], "at": [113], "dose": [114], "level": [115], "(1": [117], "\u00d7": [118], "10": [119], "6": [120], "per": [124], "kg": [125], "administered": [126, 141], "intravenously).": [127], "Patients": [128], "who": [129], "exhibited": [130, 172], "benefit": [132], "eligible": [134], "subsequent": [136], "cell": [139, 197], "infusions": [140], "intracerebroventricularly": [142], "3": [143], "Toxicity": [145], "was": [146, 156, 165], "largely": [147], "related": [148], "to": [149], "location": [151], "tumour": [154], "reversible": [157], "intensive": [159], "supportive": [160], "care.": [161], "On-target,": [162], "off-tumour": [163], "toxicity": [164], "not": [166], "observed.": [167], "Three": [168], "radiographic": [175], "improvement.": [176], "Pro-inflammatory": [177], "cytokine": [178], "levels": [179], "plasma": [184], "cerebrospinal": [186, 200], "fluid.": [187], "Transcriptomic": [188], "analyses": [189], "65,598": [191], "single": [192], "products": [198], "fluid": [201], "elucidate": [202], "heterogeneity": [203], "response": [205], "between": [206], "participants": [207], "administration": [209], "routes.": [210], "These": [211], "early": [212], "results": [213], "underscore": [214], "promise": [216], "this": [218], "therapeutic": [219], "approach": [220], "DMG.": [229]}